News
Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the company’s mRNA-1010 flu vaccine’s efficacy was nearly 27 percent ...
Newly unveiled renderings of the Wallis Annenberg Wildlife Crossing’s secondary structure, diagrams of the innovative engineering and science behind the living soil placement over its surface earlier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results